Drug profile · INN
tavaborole
TAVABOROLE
tavaborole (TAVABOROLE) is a leucine-trna ligase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — tavaborole
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
tavaborole (TAVABOROLE) is a leucine-trna ligase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Leucine-tRNA ligase inhibitor
Primary target: Leucine-tRNA ligase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is tavaborole?
tavaborole (TAVABOROLE) is a leucine-trna ligase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for tavaborole?
TAVABOROLE is a marketed brand name for tavaborole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tavaborole?
tavaborole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.